Cancer Control and Outcomes Program

The Cancer Control and Outcomes Program addresses a broad range of research questions along the cancer control continuum, which the National Cancer Institute defines as including cancer prevention, screening/early detection, diagnosis, treatment, and survivorship. This program contains four large scientific committees, by specialty (shown at right). Together, researchers in this program seek scientific advances along the continuum that can significantly reduce the burden of cancer on individual and societal levels.

This program is the centerpiece for the ECOG-ACRIN NCORP Research Base. Members of this Base use the rich resources of the Biomarker Sciences Program, with its laboratory sciences and imaging core facilities, and participate with the 12 cancer-type-oriented committees of the Therapeutic Studies Program to design and conduct treatment trials.

Thus, the Cancer Control and Outcomes Program is a critical and distinct part of the Group’s core mission and integrates Research Base scientific activities into ECOG-ACRIN's scientific culture. From this platform, therapeutic and translational discoveries in highly-focused clinical studies are broadened to larger diverse populations, are subject to rigorous analysis of patient benefit in terms of quality of life, and applied to earlier stages in the carcinogenesis process.

Program Co-Directors



Lynne I. Wagner, PhD

Wake Forest School of Medicine
Biography

Represents the program as a deputy chair on the Executive Committee

 

Mitchell D. Schnall, MD, PhD

University of Pennsylvania
Biography

 

Peter J. O’Dwyer, MD

University of Pennsylvania and the Abramson Cancer Center
Biography

 

Community Advisory Committee



Chair

Co-Chair

Co-Chair

Michael A. Thompson, MD, PhD

Aurora NCORP
Biography

 

Al B. Benson III, MD, FACP, FASCO

Northwestern University and the Robert H. Lurie Comprehensive Cancer Center
Biography

 

Mary Lou Smith, JD, MBA

Research Advocacy Network
Biography